Loading...

AnGes, Inc.

AMGXFPNK
Healthcare
Biotechnology
$0.36
$0.00(0.00%)

AnGes, Inc. (AMGXF) Stock Competitors & Peer Comparison

See (AMGXF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
AMGXF$0.36+0.00%127.1M-0.46-$0.79N/A
NONOF$69.94-0.19%320.7B19.58$3.69+2.37%
CSLLY$88.17-0.92%170.8B32.29$2.73+1.50%
CMXHF$175.70-1.19%85.1B32.18$5.46+1.52%
UCBJF$213.55+1.62%41.2B33.99$6.37+0.73%
UCBJY$105.14+0.11%39.9B32.73$3.21+0.75%
ARGNF$547.60+0.00%33.5B33.45$16.37N/A
ODTC$22,005.00+29.44%24.1B1.07$20,580.00N/A
IVBXF$11.50+0.00%19.7B-1150.00-$0.01N/A
WXIBF$4.00+5.26%16.3B36.36$0.11N/A
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

AMGXF vs NONOF Comparison July 2025

AMGXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AMGXF stands at 127.1M. In comparison, NONOF has a market cap of 320.7B. Regarding current trading prices, AMGXF is priced at $0.36, while NONOF trades at $69.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AMGXF currently has a P/E ratio of -0.46, whereas NONOF's P/E ratio is 19.58. In terms of profitability, AMGXF's ROE is -0.24%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, AMGXF is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for AMGXF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;